从因瘀致郁论治卒中后抑郁

谭艳; 曹洋; 罗敏辉; 夏叶婉; 王鑫; 牛子青; 章薇

doi:10.14148/j.issn.1672-0482.2023.0507

从因瘀致郁论治卒中后抑郁

doi: 10.14148/j.issn.1672-0482.2023.0507

湖南中医药大学第一附属医院，湖南长沙 410007

基金项目:

国家自然科学基金面上项目 81973956

详细信息

作者简介:
谭艳，女，博士研究生，E-mail：1402245779@qq.com

通讯作者:
章薇，女，教授，博士生导师，主要从事经脉脏腑相关研究，E-mail：507395550@qq.com

中图分类号: R277.7
计量
- 文章访问数: 197
- HTML全文浏览量: 45
- PDF下载量: 41
- 被引次数: 0
出版历程
- 收稿日期: 2022-05-24
- 网络出版日期: 2023-06-12
- 发布日期: 2023-06-10

Treating Poststroke Depression from the Perspective of Depression Caused by Stagnation

The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410007, China

摘要

摘要: 卒中后抑郁是脑卒中后常见的并发症，对脑卒中患者的预后产生深远影响。介绍了因瘀致郁理论渊源，因瘀致郁病机内涵主要包括两点：脑络瘀阻，神机失用；心神失养，郁证乃生。并对因瘀致郁与卒中后抑郁的现代生物学机制进行探讨，认为卒中后抑郁病理机制与低脑血流量、血小板功能障碍、内皮功能损伤、脂代谢异常、炎症反应等因素密切相关。从形神共治的角度提出卒中后抑郁的治疗以活血解郁为主，不仅要对卒中本身进行治疗，还要重视因病而导致的心理障碍的识别与干预。
- 卒中后抑郁 /
- 郁证 /
- 血瘀 /
- 形神共治
Abstract: Poststroke depression is a common complication after stroke, which has a profound impact on the prognosis of stroke patients. The article introduced the origin of the depression caused by stagnation theory. The pathogenesis connotation of the theory mainly includes two points: cerebral collateral stasis leading to vital activity dysfunction; nourishment deprivation of heart spirit leading to depression. The article also explored the modern biological mechanisms of depression caused by stagnation as well as poststroke depression. It is believed that the pathological mechanism of poststroke depression is closely related to factors such as low cerebral blood flow, platelet dysfunction, endothelial dysfunction, abnormal lipid metabolism, and inflammatory response. From the perspective of the joint treatment of body and spirit, it is proposed that the treatment of poststroke depression should mainly focus on promoting blood circulation and relieving depression. It is not only necessary to treat the stroke itself, but also to pay attention to the identification and intervention of psychological disorders caused by the disease.
- poststroke depression /
- depression syndrome /
- blood stasis /
- co-governance of form and spirit

HTML全文

参考文献(68)

[1]	IADECOLA C, BUCKWALTER MS, ANRATHER J. Immune responses to stroke: Mechanisms, modulation, and therapeutic potential[J]. J Clin Invest, 2020, 130(6): 2777-2788. doi: 10.1172/JCI135530
[2]	古求知. 肘后备急方校注[M]. 北京: 中医古籍出版社, 2015: 1-13. GU QZ. Emergency Formulas to Keep Up One's Sleeve Correction Note[M]. Beijing: Chinese medicine ancient books publishing house, 2015: 1-13.
[3]	AYERBE L, AYIS S, WOLFE CD, et al. Natural history, predictors and outcomes of depression after stroke: Systematic review and meta-analysis[J]. England, 2013, 202(1): 14-21.
[4]	HACKETT ML, PICKLES K. Frequency of depression after stroke: An updated systematic review and meta-analysis of observational studies[J]. Int J Stroke, 2014, 9(8): 1017-1025. doi: 10.1111/ijs.12357
[5]	DAS J, RAJANIKANT GK. Post stroke depression: The sequelae of cerebral stroke[J]. Neurosci Biobehav Rev, 2018, 90: 104-114. doi: 10.1016/j.neubiorev.2018.04.005
[6]	ROBINSON RG, JORGE RE. Post-stroke depression: A review[J]. Am J Psychiatry, 2016, 173(3): 221-231. doi: 10.1176/appi.ajp.2015.15030363
[7]	张翼. 郁证的治疗[M]. 西宁: 青海人民出版社, 1991: 2. ZHANG Y. Treatment of Depression Syndrome[M]. Xining: Qinghai people's publishing house, 1991: 2.
[8]	张介宾. 景岳全书[M]. 北京: 中国中医药出版社, 1994: 242. ZHANG JB. The Complete Works of Zhang Jing-yue[M]. Beijing: China traditional Chinese medicine press, 1994: 242.
[9]	刘斌. 卒中后抑郁的中医研究进展[J]. 中西医结合心脑血管病杂志, 2016, 14(23): 2779-2782. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY201623018.htm LIU B. Progress in research on post-stroke depression in traditional Chinese medicine[J]. Chin J Integr Med Cardio Cerebrovasc Dis, 2016, 14(23): 2779-2782. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY201623018.htm
[10]	李昌明, 陈健, 黄佳钦, 等. 从气血水理论探讨中风病分期诊疗新思路[J]. 环球中医药, 2021, 14(9): 1598-1604. https://www.cnki.com.cn/Article/CJFDTOTAL-HQZY202109013.htm LI CM, CHEN J, HUANG JC, et al. Discussion on the new diagnosis and treatment of stroke from Qiblood-water[J]. Global Chinese medicine, 2021, 14(9): 1598-1604. https://www.cnki.com.cn/Article/CJFDTOTAL-HQZY202109013.htm
[11]	王清任. 医林改错[M]. 天津: 天津科学技术出版社, 1999: 25. WANG QR. Correction of Errors in Medical Works[M]. Tianjin: Tianjin science and technology press, 1999: 25.
[12]	SOH Y, TIEMEIER H, KAWACHI I, et al. Eight-year depressive symptom trajectories and incident stroke: A 10-year follow-up of the HRS (health and retirement study)[J]. Stroke, 2022, 53(8): 2569-2576. doi: 10.1161/STROKEAHA.121.037768
[13]	张隐庵. 黄帝内经素问集注[M]. 太原: 山西科学技术出版社, 2012: 92-95. ZHANG YN. Collected Commentaries on The Yellow Emperor's Inner Classic: Basic Questions[M]. Taiyuan: Shanxi science and technology press, 2012: 92-95.
[14]	陈无择. 三因极一病证方论[M]. 北京: 中国中医药出版社, 2007: 317-320. CHEN WC. Treatise on Diseases, Patterns, and Formulas Related to the Unification of the Three Etiologies[M]. Beijing: China press of traditional Chinese medicine, 2007: 317-320.
[15]	吴谦. 医宗金鉴[M]. 沈阳: 辽宁科学技术出版社, 1997: 63, 807. WU Q. Golden Mirror of the Medical Tradition[M]. Shenyang: Liaoning science and technology press, 1997: 63, 807.
[16]	黄帝内经素问[M]. 北京: 中医古籍出版社, 2003: 26. The Yellow Emperor's Inner Classic: Basic Questions[M]. Beijing: Chinese medicine ancient books publishing house, 2003: 26.
[17]	灵枢经[M]. 北京: 人民卫生出版社, 1963: 62, 113. Miraculous Pivot[M]. Beijing: The people's medical publishing house, 1963: 62, 113.
[18]	杨上善. 黄帝内经太素[M]. 北京: 人民卫生出版社, 1965: 470. YANG SS. Grand Simplicity of The Yellow Emperor's Inner Classic[M]. Beijing: The people's medical publishing house, 1965: 470.
[19]	张介宾. 类经[M]. 北京: 中国中医药出版社, 1997: 248. ZHANG JB. The Classified Classic[M]. Beijing: China press of traditional Chinese medicine, 1997: 248.
[20]	巢元方. 诸病源候论[M]. 北京: 人民卫生出版社, 1955: 196. CHAO YF. Treatise on the Origins and Manifestations of Various Diseases[M]. Beijing: The people's medical publishing house, 1955: 196.
[21]	金妍, 田思胜, 王栋先. 血瘀证的病理机制研究近况[J]. 广州中医药大学学报, 2017, 34(1): 145-148. doi: 10.13359/j.cnki.gzxbtcm.2017.01.035 JIN Y, TIAN SS, WANG DX, et al. Recent research on the pathological mechanism of blood stasis syndrome[J]. J Guangzhou Univ Tradit Chin Med, 2017, 34(1): 145-148. doi: 10.13359/j.cnki.gzxbtcm.2017.01.035
[22]	DONNELLY J, BUDOHOSKI K P, SMIELEWSKI P, et al. Regulation of the cerebral circulation: Bedside assessment and clinical implications[J]. Crit Care, 2016, 20(1): 129. doi: 10.1186/s13054-016-1293-6
[23]	KLEIM J A, BRUNEAU R, CALDER K, et al. Functional organization of adult motor cortex is dependent upon continued protein synthesis[J]. Neuron, 2003, 40(1): 167-176. doi: 10.1016/S0896-6273(03)00592-0
[24]	CHIAPPELLI J, ADHIKARI BM, KVARTA MD, et al. Depression, stress and regional cerebral blood flow[J]. J Cereb Blood Flow Metab, 2023, 43(5): 791-800. doi: 10.1177/0271678X221148979
[25]	ONODA K, KURODA Y, YAMAMOTO Y, et al. Post-stroke apathy and hypoperfusion in basal ganglia: SPECT study[J]. Cerebrovasc Dis, 2011, 31(1): 6-11. doi: 10.1159/000319771
[26]	MAURYA PK, QAVI A, DESWAL S, et al. A comparative study of regional cerebral blood flow asymmetry index in stroke patients with or without poststroke depression using (99m) Tc-ECD single-photon emission computed tomography[J]. World J Nucl Med, 2022, 21(3): 222-230. doi: 10.1055/s-0042-1751056
[27]	GRASSO MG, PANTANO P, RICCI M, et al. Mesial temporal cortex hypoperfusion is associated with depression in subcortical stroke[J]. Stroke, 1994, 25(5): 980-985. doi: 10.1161/01.STR.25.5.980
[28]	CASSIDY EM, WALSH MT, O'CONNOR R, et al. Platelet surface glycoprotein expression in post-stroke depression: A preliminary study[J]. Psychiatry Res, 2003, 118(2): 175-181. doi: 10.1016/S0165-1781(03)00062-3
[29]	LEDERBOGEN F, GILLES M, MARAS A, et al. Increased platelet aggregability in major depression?[J]. Psychiatry Res, 2001, 102(3): 255-261. doi: 10.1016/S0165-1781(01)00259-1
[30]	CHU SG, BECKER RC, BERGER PB, et al. Mean platelet volume as a predictor of cardiovascular risk: A systematic review and meta-analysis[J]. J Thromb Haemost, 2010, 8(1): 148-156. doi: 10.1111/j.1538-7836.2009.03584.x
[31]	CANAN F, DIKICI S, KUTLUCAN A, et al. Association of mean platelet volume with DSM-Ⅳ major depression in a large community-based population: The MELEN study[J]. J Psychiatr Res, 2012, 46(3): 298-302. doi: 10.1016/j.jpsychires.2011.11.016
[32]	MUSCARI A, PUDDU GM, CENNI A, et al. Mean platelet volume (MPV) increase during acute non-lacunar ischemic strokes[J]. Thromb Res, 2009, 123(4): 587-591. doi: 10.1016/j.thromres.2008.03.025
[33]	QIU H, LIU Y, HE H, et al. The association between mean platelet volume levels and poststroke depression[J]. Brain Behav, 2018, 8(10): e01114. doi: 10.1002/brb3.1114
[34]	杨会珍, 胡广, 苗兰, 等. 肾上腺素致慢性血瘀证大鼠模型的血浆代谢组学研究[J]. 中国中医基础医学杂志, 2022, 28(2): 205-209. doi: 10.19945/j.cnki.issn.1006-3250.2022.02.024 YANG HZ, HU G, MIAO L, et al. Plasma metabonomics of the rat model of chronic blood stasis syndrome induced by epinephrine[J]. J Basic Chin Med, 2022, 28(2): 205-209. doi: 10.19945/j.cnki.issn.1006-3250.2022.02.024
[35]	GODO S, SHIMOKAWA H. Endothelial functions[J]. Arterioscler Thromb Vasc Biol, 2017, 37(9): e108-e114.
[36]	WACLAWOVSKY AJ, DE BRITO E, SMITH L, et al. Endothelial dysfunction in people with depressive disorders: A systematic review and meta-analysis[J]. J Psychiatr Res, 2021, 141: 152-159. doi: 10.1016/j.jpsychires.2021.06.045
[37]	GROSS P L, AIRD W C. The endothelium and thrombosis[J]. Semin Thromb Hemost, 2000, 26(5): 463-478. doi: 10.1055/s-2000-13202
[38]	NITZSCHE A, POITTEVIN M, BENARAB A, et al. Endothelial S1P(1) signaling counteracts infarct expansion in ischemic stroke[J]. Circ Res, 2021, 128(3): 363-382. doi: 10.1161/CIRCRESAHA.120.316711
[39]	BROADLEY A J, KORSZUN A, ABDELAAL E, et al. Metyrapone improves endothelial dysfunction in patients with treated depression[J]. J Am Coll Cardiol, 2006, 48(1): 170-175. doi: 10.1016/j.jacc.2005.12.078
[40]	CAO JX, LIU L, SUN YT, et al. Escitalopram improves neural functional prognosis and endothelial dysfunction in patients with acute cerebral infarction[J]. Restor Neurol Neurosci, 2020, 38(5): 385-393.
[41]	WANG Z, SHI Y, LIU F, et al. Diversiform etiologies for post-stroke depression[J]. Front Psychiatry, 2018, 9: 761. doi: 10.3389/fphys.2018.00761
[42]	SPALLETTA G, BRIA P, CALTAGIRONE C. Sensitivity of somatic symptoms in post-stroke depression (PSD)[J]. Int J Geriatr Psychiatry, 2005, 20(11): 1103-1104. doi: 10.1002/gps.1399
[43]	SONG C, WANG H. Cytokines mediated inflammation and decreased neurogenesis in animal models of depression[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2011, 35(3): 760-768. doi: 10.1016/j.pnpbp.2010.06.020
[44]	CONNOR T J, LEONARD BE. Depression, stress and immunological activation: The role of cytokines in depressive disorders[J]. Life Sci, 1998, 62(7): 583-606. doi: 10.1016/S0024-3205(97)00990-9
[45]	王姗姗, 陈海英, 孙虹, 等. 大脑中动脉栓塞后慢性不可预见性应激大鼠下丘脑肿瘤坏死因子α及其信号通路的激活[J]. 生理学报, 2014, 66(4): 463-468. doi: 10.13294/j.aps.2014.0054 WANG SS, CHEN HY, SUN H, et al. Activation of TNF-α and signaling pathway in the hypothalamus of the rats subjected to chronic unpredictable mild stressors after middle cerebral artery occlusion[J]. Acta Physiologica Sinica, 2014, 66(4): 463-468. doi: 10.13294/j.aps.2014.0054
[46]	HU J, WANG L, FAN K, et al. The association between systemic inflammatory markers and post-stroke depression: A prospective stroke cohort[J]. Clin Interv Aging, 2021, 16: 1231-1239. doi: 10.2147/CIA.S314131
[47]	ADIBHATLA RM, DEMPSY R, HATCHER JF. Integration of cytokine biology and lipid metabolism in stroke[J]. Front Biosci, 2008, 13: 1250-1270. doi: 10.2741/2759
[48]	ADIBHATLA RM, HATCHER JF, DEMPSEY RJ. Lipids and lipidomics in brain injury and diseases[J]. AAPS J, 2006, 8(2): 314-321. doi: 10.1007/BF02854902
[49]	XU HB, ZHANG RF, LUO D, et al. Comparative proteomic analysis of plasma from major depressive patients: Identification of proteins associated with lipid metabolism and immunoregulation[J]. Int J Neuropsychopharmacol, 2012, 15(10): 1413-1425. doi: 10.1017/S1461145712000302
[50]	PEDRO-BOTET J, SENTIM, NOGUES X, et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism[J]. Stroke, 1992, 23(11): 1556-1562. doi: 10.1161/01.STR.23.11.1556
[51]	JIANG W, GONG L, LIU F, et al. Alteration of gut microbiome and correlated lipid metabolism in post-stroke depression[J]. Front Cell Infect Microbiol, 2021, 11: 663967. doi: 10.3389/fcimb.2021.663967
[52]	DALILE B, VAN OUDENHOVE L, VERVLIET B, et al. The role of short-chain fatty acids in microbiota-gut-brain communication[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(8): 461-478. doi: 10.1038/s41575-019-0157-3
[53]	YU H, QIN X, YU Z, et al. Effects of high-fat diet on the formation of depressive-like behavior in mice[J]. Food Funct, 2021, 12(14): 6416-6431. doi: 10.1039/D1FO00044F
[54]	HALEY MJ, WHITE CS, ROBERTS D, et al. Stroke induces prolonged changes in lipid metabolism, the liver and body composition in mice[J]. Transl Stroke Res, 2020, 11(4): 837-850. doi: 10.1007/s12975-019-00763-2
[55]	傅梦薇, 刘咏梅, 陈恒文, 等. 冠心病血瘀证蛋白组学研究的系统综述[J]. 世界科学技术-中医药现代化, 2020, 22(11): 3819-3826. https://www.cnki.com.cn/Article/CJFDTOTAL-SJKX202011006.htm FU MW, LIU YM, CHEN HW, et al. Systematic review of proteomics research of coronary heart disease with blood stasis syndrome[J]. Mod Tradit Chin Med Mater Med World Sci Technol, 2020, 22(11): 3819-3826. https://www.cnki.com.cn/Article/CJFDTOTAL-SJKX202011006.htm
[56]	EVERSON SA, ROBERTS RE, GOLDBERG DE, et al. Depressive symptoms and increased risk of stroke mortality over a 29-year period[J]. Arch Intern Med, 1998, 158(10): 1133-1138. doi: 10.1001/archinte.158.10.1133
[57]	HOIRISCH-CLAPAUCH S, NARDI AE, GRIS JC, et al. Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects?[J]. Thromb Res, 2014, 134(1): 11-16. doi: 10.1016/j.thromres.2014.02.028
[58]	MORTENSEN JK, JOHNSEN SP, LARSSON H, et al. Early antidepressant treatment and all-cause 30-day mortality in patients with ischemic stroke[J]. Cerebrovasc Dis, 2015, 40(1/2): 81-90.
[59]	SHIN D, OH YH, EOM CS, et al. Use of selective serotonin reuptake inhibitors and risk of stroke: A systematic review and meta-analysis[J]. J Neurol, 2014, 261(4): 686-695. doi: 10.1007/s00415-014-7251-9
[60]	冯蓓蕾, 王翘楚, 李正元. 解郁活血方对脑梗死后抑郁症患者神经功能康复的影响[J]. 中西医结合学报, 2004(3): 182-184. https://www.cnki.com.cn/Article/CJFDTOTAL-XBZX200403008.htm FENG BL, WANG QC, LI ZY. Influence of Jieyu Huoxue Decoction on rehabilitation of patients with depression after cerebral infarction[J]. J Integr Med, 2004, 2(3): 182-184. https://www.cnki.com.cn/Article/CJFDTOTAL-XBZX200403008.htm
[61]	FAN W, WANG Q, YAN Y. Influence of Xingnao Jieyu capsule on hippocampal and frontal lobe neuronal growth in a rat model of post-stroke depression[J]. Neural Regen Res, 2012, 7(3): 187-190.
[62]	YAN Y, LI T, WANG D, et al. Antidepressant effect of Xingnao Jieyu decoction mediated by alleviating neuroinflammation in a rat model of post-stroke depression[J]. J Tradit Chin Med, 2019, 39(5): 658-666.
[63]	LI T, WANG D, ZHAO B, et al. Xingnao Jieyu Decoction ameliorates poststroke depression through the BDNF/ERK/CREB pathway in rats[J]. Evid Based Complement Alternat Med, 2018, 2018: 5403045.
[64]	LUO L, DENG S, YI J, et al. Buyang Huanwu Decoction ameliorates poststroke depression via promoting neurotrophic pathway mediated neuroprotection and neurogenesis[J]. Evid Based Complement Alternat Med, 2017, 2017: 4072658.
[65]	汪宁, 邓奕, 何群, 等. 通窍活血汤含药血清对谷氨酸损伤的PC12细胞的保护作用[J]. 中国中药杂志, 2010, 35(10): 1307-1310. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY201010021.htm WANG N, DENG Y, HE Q, et al. Protective effect of Tongqiao Huoxue Tang serum on PC12 cells injured by glutamate[J]. China J Chin Mater Med, 2010, 35(10): 1307-1310. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY201010021.htm
[66]	ZHANG Y, LI L, ZHANG J. Curcumin in antidepressant treatments: An overview of potential mechanisms, pre-clinical/clinical trials and ongoing challenges[J]. Basic Clin Pharmacol Toxicol, 2020, 127(4): 243-253. doi: 10.1111/bcpt.13455
[67]	秦宇雯, 费程浩, 张伟, 等. 姜黄属中药活血化瘀功效关联物质研究进展[J]. 中国中药杂志, 2022, 47(1): 24-35. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202201004.htm QIN YW, FEI CH, ZHANG W, et al. Research progress on the related substances of promoting blood circulation and removing blood stasis in Curcuma[J]. China J Chin Mater Med, 2022, 47(1): 24-35. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202201004.htm
[68]	苑杰. 卒中后抑郁[M]. 南昌: 江西科学技术出版社, 2018: 16. YUAN J. Post Stroke Depression[M]. Nanchang: Jiangxi science and technology press, 2018: 16.